[1]余明艳,李 芳.尿激酶静脉溶栓治疗对急性轻型脑卒中患者血清脂蛋白相关磷脂酶A2、可溶性血管细胞黏附分子-1、基质金属蛋白酶-9水平及神经功能的影响[J].陕西医学杂志,2021,50(1):79-81,85.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.021]
　YU Mingyan,LI Fang.Effects of intravenous thrombolysis with urokinase on Lp-PLA2,sVCAM-1,MMP-9 levels and neurological function in patients with acute mild stroke[J].,2021,50(1):79-81,85.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.021]
点击复制

尿激酶静脉溶栓治疗对急性轻型脑卒中患者血清脂蛋白相关磷脂酶A2、可溶性血管细胞黏附分子-1、基质金属蛋白酶-9水平及神经功能的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年1期
页码:
79-81,85
栏目:
药物与临床
出版日期:
2021-01-05

文章信息/Info

Title:
Effects of intravenous thrombolysis with urokinase on Lp-PLA2,sVCAM-1,MMP-9 levels and neurological function in patients with acute mild stroke
作者:
余明艳1; 2; 李 芳1
(1.锦州医科大学附属第一医院神经内科,辽宁 锦州 121000; 2.辽宁省鞍山市长大医院神经内科,辽宁 鞍山 114000)
Author(s):
YU Mingyan; LI Fang
(Department of Neurology,the First Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000,China)
关键词:
急性轻型脑卒中;  尿激酶;  静脉溶栓;  脂蛋白相关磷脂酶A2;  可溶性血管细胞黏附分子-1;  基质金属蛋白酶-9;  神经功能
Keywords:
Acute mild stroke;  Urokinase;  Intravenous thrombolysis;  Lipoprotein-associated phospholipase A2;  Soluble vascular cell adhesion molecule-1;  Matrix metalloproteinase-9;  Neurological function
分类号:
R 743.3
DOI:
DOI:10.3969/j.issn.1000-7377.2021.01.021
文献标志码:
A
摘要:
目的:探讨尿激酶静脉溶栓治疗对急性轻型脑卒中患者血清脂蛋白相关磷脂酶A2(Lp-PLA2)、可溶性血管细胞黏附分子-1(sVCAM-1)、基质金属蛋白酶-9(MMP-9)水平及神经功能的影响。方法:选取96例急性轻型脑卒中患者,根据是否接受溶栓治疗分为溶栓组(53例)、非溶栓组(43例)。溶栓组予以尿激酶静脉滴入+抗血小板治疗,非溶栓组予以抗血小板治疗,两组均治疗7 d。观察两组入院时、治疗24 h、7 d后的神经功能; 入院时、治疗7 d后的血清细胞因子水平及研究期间不良反应发生情况。结果:治疗后24 h、7 d后,两组的卒中量表(NHISS)评分为0～2分患者所占比例均较入院时升高,且溶栓组高于非溶栓组(92.50%、88.70%与75.60%、69.00%,P<0.05)。治疗7 d后,两组血清Lp-PLA2、sVCAM-1、MMP-9水平均较入院时降低,且溶栓组低于非溶栓组(P<0.05)。研究期间,两组不良反应发生率相比无统计学差异(P>0.05)。结论:尿激酶静脉溶栓治疗急性轻型脑卒中,可有效降低患者血清Lp-PLA2、sVCAM-1、MMP-9水平,控制机体炎症反应,并改善其神经功能,且安全性良好。
Abstract:
Objective:To study the effects of intravenous thrombolysis with urokinase on serum Lp-PLA2,sVCAM-1,MMP-9 levels and neurological function in patients with acute mild stroke.Methods:96 patients with acute mild stroke were divided into thrombolytic group(53 cases)and non-thrombolytic group(43 cases)according to whether they received thrombolytic therapy.Intravenous urokinase plus antiplatelet therapy was given in the thrombolytic group,and antiplatelet therapy was given in the non-thrombolytic group,both groups were treated for 7 days.The neurological function at admission,24 hours and 7 days after treatment,serum cytokine levels at admission and 7 days after treatment,and adverse reactions during the study period were compared.Results:24 hours and 7 days after treatment,the proportion of patients with NHISS score of 0-2 in both groups increased than those at admission,and the thrombolytic group was higher than the non-thrombolytic group(92.50% vs.75.60%,88.70% vs.69.00%,P<0.05).After 7 days of treatment,the levels of serum Lp-PLA2,sVCAM-1 and MMP-9 in the two groups were lower than those at admission,and the thrombolytic group was lower than the non-thrombolytic group(P<0.05).During the study period,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Intravenous thrombolysis with urokinase can effectively reduce the levels of serum Lp-PLA2,sVCAM-1 and MMP-9,control the inflammatory reaction,improve their neurological function with good safety.

参考文献/References:

[1] 金硕果,尹海燕,孙鸿辉,等.三七对轻型缺血性脑卒中患者“双抗”治疗后出血事件影响的研究[J].陕西中医,2009,40(3):287-289.
[2] 王伊龙,赵性泉,刘新峰,等.高危非致残性缺血性脑血管事件诊疗指南[J].中国卒中杂志,2016,11(6):481-491.
[3] 丁立东,肖章红,茆华武,等.老年轻型急性缺血性脑卒中患者早期静脉溶栓治疗的疗效及安全性评估[J].中华老年医学杂志,2019,38(12):1344-1347.
[4] 戴美芬,包黎刚,徐冬娟,等.轻型急性缺血性脑卒中患者静脉溶栓治疗的有效性和安全性分析[J].中华老年心脑血管病杂志,2016,18(10):1070-1072.
[5] 彭 斌,吴 波.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
[6] 李亚斌,李 刚,王希瑞,等.依达拉奉辅助亚低温对重型颅脑创伤的血清细胞因子及凝血功能的影响[J].中华神经创伤外科电子杂志,2020,6(3):166-171.
[7] 童燕娜,韩臻臻,段洪连,等.轻型缺血性脑卒中静脉溶栓的疗效及安全性观察[J].中西医结合心脑血管病杂志,2020,18(2):341-344.
[8] Messe SR,Khatri P,Reeves MI,el al.Why are acute ischemic stroke patients not receiving lv tpa results from a national registry[J].Neurology,2016,87(15):1565-1574.
[9] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国临床医生,2011,39(3):67-73.
[10] 申春云,蔡林江,高俊杰,等.尿激酶静脉溶栓治疗急性轻型卒中的有效性和安全性分析[J].广州医科大学学报,2018,46(5):35-38..
[11] 杜伟杰,李 威,方 玲,等.尿激酶静脉溶栓治疗急性轻型缺血性脑卒中疗效观察[J].山东医药,2017,57(31):82-84.
[12] 蒋月丽,解龙昌,梁 冬,等.Lp-PLA2、TNF-α及CRP在急性缺血性脑卒中患者中的表达及意义[J].西部医学,2019,31(11):1709-1714.
[13] 李菁晶,鞠 奕,潘岳松,等.轻型缺血性脑卒中患者急性期神经功能恶化的相关因素分析[J].中华老年心脑血管病杂志,2016,18(7):715-718.
[14] 吴小杨,黄艮彬,林齐防,等.轻型急性缺血性脑卒中患者静脉溶栓治疗的疗效分析[J].卒中与神经疾病,2019,26(3):271-276.
[15] 张 靖,舒 民,姚明言,等.血栓抽吸联合重组人尿激酶原预处理对高血栓负荷STEMI患者冠脉血流及心肌灌注的影响[J].天津医药,2020,48(6):539-542.

相似文献/References:

[1]栾百婷,罗 涛,程洪瑜,等.脑出血患者穿刺引流术后尿激酶应用剂量和时间研究*[J].陕西医学杂志,2020,49(11):1399.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.008]
　LUAN Baiting,LUO Tao,CHENG Hongyu,et al.Study on the dose and timing of the application of urokinase after puncture drainage in patients with intracerebral hemorrhage[J].,2020,49(1):1399.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.008]
[2]郑明非,高继东,冯 喆,等.改良手动血栓清除术联合导管直接溶栓术治疗急性髂股静脉血栓临床疗效研究[J].陕西医学杂志,2021,50(5):583.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.017]
　ZHENG Mingfei,GAO Jidong,FENG Zhe,et al.Curative effect of modified manual thrombectomy combined with catheter-directed thrombolysis in treatment of acute iliofemoral vein thrombosis[J].,2021,50(1):583.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.017]
[3]江耿思,刘小红,陈桂增,等.立体定向脑内血肿穿刺引流中血肿腔与脑脊液相通与否排空效果的对比研究[J].陕西医学杂志,2021,50(6):717.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.019]

更新日期/Last Update: 2021-01-05